Curriculum · Screening (National/International)
Lipid screening in adults
The row as the screening table writes it
Hyperlipidemia appears as one row of a Common Screening Programs table, and the table is set out as Disease/Condition, Screening Test, Who to Screen, and Frequency / Key Point. The row reads:
- Screening Test: lipid profile
- Who to Screen: adults with risk factors or by age guideline
- Frequency / Key Point: usually every 4-6 yrs
The three questions, answered
- The investigation of choice is the lipid profile. Not a fasting glucose, not an HbA1c - those are the diabetes mellitus type 2 row of the same table.
- Who to screen: adults with risk factors or by age guideline. Unlike the rows around it, the lipid row gives no age range of its own, so the age comes from the guideline in use, and the risk factors stand on their own.
- How often: usually every 4-6 yrs. That is a longer gap than diabetes mellitus type 2 at every 3 yrs, and shorter than colorectal cancer by colonoscopy at every 10 yrs.
What the result is used for
Statins are beneficial for both primary and secondary prevention of cardiovascular disease, but the benefit is greater when the baseline risk is greater. Current guidelines would not support statin therapy for a patient with a 10-year risk of atherosclerotic cardiovascular disease (ASCVD) below 5%.
- Fish oil supplements have not proven to be useful for primary prevention of ASCVD.
- Niacin is no longer recommended for cardiovascular risk reduction due to a lack of evidence for benefit.